REVELATION Trademark

Trademark Overview


On Friday, September 17, 2021, a trademark application was filed for REVELATION with the United States Patent and Trademark Office. The USPTO has given the REVELATION trademark a serial number of 97033279. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, September 23, 2024. This trademark is owned by Revelation Biosciences, Inc.. The REVELATION trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

House mark for pharmaceutical products for human use, namely, pharmaceuticals for the prevention and treatment of infectious diseases, pharmaceuticals for the prevention and treatment of respiratory viral infections, pharmaceuticals for the prevention and treatment of upper respiratory viruses, and pharmaceuticals for prevention and treatment of chronic nasal congestion; house mark for pharmaceuticals products for human use, namely, vaccines; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease testing, namely, infectious diseases; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in testing for levels of cytokines; medical diagnostic test strips for use in the field of infectious diseases; medical diagnostic test strips for use in testing for levels of cytokines

Medical diagnostic apparatus for testing for levels of cytokines, viruses and/or infectious diseases
revelation

General Information


Serial Number97033279
Word MarkREVELATION
Filing DateFriday, September 17, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, September 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements


Goods and ServicesHouse mark for pharmaceutical products for human use, namely, pharmaceuticals for the prevention and treatment of infectious diseases, pharmaceuticals for the prevention and treatment of respiratory viral infections, pharmaceuticals for the prevention and treatment of upper respiratory viruses, and pharmaceuticals for prevention and treatment of chronic nasal congestion; house mark for pharmaceuticals products for human use, namely, vaccines; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease testing, namely, infectious diseases; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in testing for levels of cytokines; medical diagnostic test strips for use in the field of infectious diseases; medical diagnostic test strips for use in testing for levels of cytokines
Goods and ServicesMedical diagnostic apparatus for testing for levels of cytokines, viruses and/or infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, October 22, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRevelation Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Party NameRevelation Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Trademark Events


Event DateEvent Description
Tuesday, September 21, 2021NEW APPLICATION ENTERED
Friday, October 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 21, 2022ASSIGNED TO EXAMINER
Friday, July 1, 2022NON-FINAL ACTION WRITTEN
Friday, July 1, 2022NON-FINAL ACTION E-MAILED
Friday, July 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 1, 2022NON-FINAL ACTION WRITTEN
Friday, July 1, 2022NON-FINAL ACTION E-MAILED
Friday, July 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 19, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 19, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 7, 2023SOU EXTENSION 1 FILED
Thursday, September 7, 2023SOU EXTENSION 1 GRANTED
Saturday, September 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 20, 2024SOU EXTENSION 2 GRANTED
Wednesday, March 20, 2024SOU EXTENSION 2 FILED
Wednesday, March 20, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2024SOU EXTENSION 3 GRANTED
Monday, September 23, 2024SOU EXTENSION 3 FILED